ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

In Brief: Weinstein Names Permanent Director Of Columbia Comprehensive Center; Gottsman Heads Institute

February 8, 1985

Rumors Preceded Broder’s Move

December 22, 1994

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012